Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn’s disease. - Yacyshyn,B.R.; Chey,W.Y.; Goff,J. (Gut, 2002)